THRD Third Harmonic Bio Inc. Net earnings per share growth forecast for next year
Third Harmonic Bio (THRD) is developing a unique immunotherapy for allergies, leveraging proprietary molecules and a debt-free balance sheet. The growth trajectory for next year's EPS reflects analyst expectations, with the metric currently standing at 0.00. While success depends on clinical trial results and new investments, the asset's isolation from macroeconomic volatility makes it a reliable defensive asset.
thirdharmonicbio.com - analytical breakdowns and key metrics (THRD)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Third Harmonic Bio|THRD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Third Harmonic Bio, Inc.|THRD - Company Total Debt Obligations|Debt to Book Capitalization Ratio Third Harmonic Bio|THRD - Company Long-Term Loans and Borrowings|Company Short-Term Debts Third Harmonic Bio|Quick Liquidity Indicator thirdharmonicbio.com
- earnings and valuation multiples information:
THRD - Final Profit|Projected Future Earnings Third Harmonic Bio|THRD - Company Value to Net Income|Forward P/E Multiple Third Harmonic Bio|THRD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Third Harmonic Bio|THRD - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Third Harmonic Bio|THRD - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months thirdharmonicbio.com|THRD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Third Harmonic Bio
- total revenue and sales volume data:
Initial company analysis:THRD, Third Harmonic Bio, Inc
Third Harmonic Bio's reliance on cross-border clinical trials and patent law leaves the business vulnerable to geopolitical risks. The profit growth forecast for the coming year smooths out market noise, reflecting the consensus valuation of future profitability and the company's ability to service its debt. The positive trend on this chart confirms the resilience of drug development, while a decline signals rising financial risks.
Competitor analysis for Third Harmonic Bio
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|KNSA: Expected earnings per share growth for next year|Grifols Biemat - Projected earnings per share increase next year|ADPT: Earnings growth forecast for next year|celldex.com - Expected earnings per share trend next year|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|BioCryst Pharmaceuticals, Inc. (BCRX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Vera Pharma (VERA)|DNTH (Dianthus Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|ABCL: Projected earnings per share growth rate for next year|TRML: Expected earnings per share growth for next year|Expected earnings per share trend next year PGEN (Precigen Inc)|PHAR: Earnings growth forecast for next year|Nektar Corp - Expected earnings per share trend next year|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|Earnings growth forecast for next year zenasbio.com|Net earnings per share growth forecast for next year Immunome (IMNM)|GOSS (Gossamer Bio Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|SEPN - Expected earnings per share growth for next year|PVLA - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year savarapharma.com|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year ANAB|ATXS (Astria Pharma) - Earnings growth forecast for next year|enGene Corp (ENGN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year RAPT|Expected earnings per share growth for next year aerovatetx.com JBIO|Aclaris Therapeutics, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year KYTX|Tiziana Life Sciences PLC - Earnings growth forecast for next year|CABA: Net earnings per share growth forecast for next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Avalo Therapeutics|Expected net earnings per share growth next year Eledon Pharmaceuticals Inc. ELDN|Expected earnings per share growth for next year AGEN (Agenus Inc)|Projected earnings per share increase next year CLYM|Earnings growth forecast for next year ZURA (Zura Bio Limited)|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|Expected earnings per share trend next year IMA (ImageneBio Inc)|STTK: Earnings growth forecast for next year|Projected earnings per share growth rate for next year EQ|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Immunic Inc - Net earnings per share change forecast for next year|Earnings growth forecast for next year ATRA|IFRX (inflarx.de) - Expected earnings per share trend next year|Earnings growth forecast for next year XFOR (X4 Pharma)|Earnings growth forecast for next year Adicet Bio Inc. ACET|CELU - Net earnings per share growth forecast for next year|Expected earnings per share trend next year INMB (inmunebio.com)|Barinthus Biotherapeutics plc (BRNS) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Kezar Life Sciences Inc.|SABS (SAB Biotherapeutics, Inc) - Earnings growth forecast for next year|Earnings growth forecast for next year Akari Therapeutics, Plc|Expected earnings per share growth for next year ENLV (Enlivex Therapeutics)|QTTB (q32bio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year GOVX (GeoVax)|Consensus forecast of earnings per share growth for next year Edesa Biotech Inc (EDSA)|IBIO - Net earnings per share growth forecast for next year|Carisma Therapeutics (CARM) - Expected earnings per share growth for next year|XTL Biopharmaceuticals (XTLB) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Bolt Biotherapeutics, Inc.|Expected earnings per share growth for next year HCWB|Earnings growth forecast for next year Aptevo|Net earnings per share growth forecast for next year AIM ImmunoTech (AIM)|aditxt.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year GRI (GRI Bio, Inc.)|xortx.com (XRTX) - Expected net earnings per share growth next year|HIND: Expected earnings per share growth for next year|Revelation Biosciences Inc - Projected earnings per share increase next year|INDP: Earnings growth forecast for next year|BiondVax Pharmaceuticals - Expected earnings per share trend next year|CALI (CalciMedica Inc) - Earnings growth forecast for next year|Affimed Therapeutics (AFMD) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Allakos Inc. (ALLK)|HOOK (hookipapharma.com) - Expected earnings per share trend next year|Earnings growth forecast for next year IGMS (IGM Biosciences)|ITOS: Projected earnings per share growth rate for next year|OCEA: Expected earnings per share growth for next year|Expected earnings per share trend next year TCBP (tcbiopharm.com)
